Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-08-05FDA Approved: VALPROIC ACID — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for Valproic acid submitted by Upsher-Smith Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Asenapine in the Treatment of Older Adults With Bipolar Disorder [Phase 4]
A Phase 4 trial update evaluating asenapine for bipolar disorder in older adults has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Tamoxifen in Treatment of Acute Mania [Phase 3]
A Phase 3 clinical trial evaluating tamoxifen for acute mania in bipolar disorder has completed, according to ClinicalTrials.gov, sponsored …
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Bipolar Disorder in Late Life
This entry reports the completion of a Duke University-sponsored clinical trial studying bipolar disorder in late life. Results were posted …
-
CLINICAL_TRIALS trial_result · 2014-07-30Clinical Trial Update: Bipolar Intervention Study: Cognitive Interpersonal Therapy [NA]
Completed clinical trial evaluating Cognitive Interpersonal Therapy for bipolar disorder. Results were posted on 2014-07-30.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-29Clinical Trial Update: Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study [Phase 3]
This Phase 3 pilot trial evaluated adding low-dose aripiprazole to standard therapy for bipolar depression. The study status is terminated.
-
EMA withdrawal · 2014-07-24EMA Withdrawn: Olanzapine Cipla (previously Olanzapine Neopharma) (olanzapine) — Cipla (EU) Limited
EMA withdrew Olanzapine Cipla (formerly Olanzapine Neopharma) in the EU; therapeutic areas include schizophrenia and bipolar disorder.
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Ziprasidone in Pediatric Bipolar Disorder [Phase 4]
Phase 4 clinical trial update for ziprasidone in pediatric bipolar disorder has completed with results posted in 2014.
-
FDA label_change · 2014-06-20FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Depakote Sprinkles (divalproex sodium) from AbbVie, updating regulatory information for the …
-
CLINICAL_TRIALS trial_result · 2014-06-20Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder [Phase 3]
A Phase 3 trial comparing flexible-dose extended-release paliperidone to quetiapine and placebo in adults with Bipolar I disorder has comple…
-
FDA approval · 2014-06-19FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
The FDA granted a supplemental approval for Depakote Sprinkles (divalproex sodium) from AbbVie under a supplemental application.
-
FDA approval · 2014-06-19FDA Approved: DEPAKOTE — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote (divalproex sodium) submitted by AbbVie Inc. The approval indicates the agency has appr…
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: Cognitive Training to Improve Work Outcomes in Severe Mental Illness [Phase 2]
A Phase 2 clinical trial evaluating cognitive training to improve work outcomes in people with schizophrenia, bipolar disorder, or major dep…
-
FDA approval · 2014-06-12FDA Approved: LAMOTRIGINE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals' lamotrigine chewable dispersible as a generic lamotrigine product under an original ANDA.
-
FDA approval · 2014-06-10FDA Approved: LAMICTAL — Supplemental Application (GlaxoSmithKline LLC)
FDA supplemental approval for Lamictal (lamotrigine) submitted by GlaxoSmithKline LLC, leading to updated labeling.
-
FDA approval · 2014-06-10FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for LAMICTAL ODT (lamotrigine) from GlaxoSmithKline LLC.
-
FDA approval · 2014-06-10FDA Approved: LAMICTAL XR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for LAMICTAL XR (lamotrigine) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2014-06-09FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote Sprinkles (divalproex sodium) submitted by AbbVie. The action involves Depakote Sprinkl…
-
FDA approval · 2014-06-09FDA Approved: DEPAKOTE ER — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Depakote ER (divalproex sodium) submitted by AbbVie.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia [Phase 4]
This Phase 4 trial compared melatonin to placebo to aid benzodiazepine discontinuation in patients with schizophrenia; the study has complet…
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients [Phase 3]
Phase 3 trial evaluating lamotrigine as add-on therapy for pediatric bipolar I disorder has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Comparative Effectiveness Study for Bipolar Disorder [Phase 4]
Phase 4 comparative effectiveness study in bipolar disorder completed; results were posted in 2014. Sponsored by Massachusetts General Hospi…
-
FDA approval · 2014-06-02FDA Approved: DIVALPROEX SODIUM — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original ANDA for divalproex sodium, enabling a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Mindfulness-Based Cognitive Therapy for Perinatal Women With Mood Disorders [Phase 1]
Phase 1 trial update reports the completion of a study evaluating mindfulness-based cognitive therapy for perinatal women with mood disorder…
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression [Phase 2]
A Phase 2 trial evaluating Lu AA39959 for bipolar depression has been terminated.